RHABDOID TUMOR
Clinical trials for RHABDOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new RHABDOID TUMOR trials appear
Sign up with your email to follow new studies for RHABDOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on childhood cancers in new trial
Disease control Recruiting nowThis early-stage trial tests a treatment where a child's own immune cells are collected, modified to better attack cancer, and given back as a one-time infusion. It is for children and young adults up to age 21 with solid tumors that have come back or not responded to standard th…
Matched conditions: RHABDOID TUMOR
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
New stem cell combo aims to fight stubborn childhood cancers
Disease control Recruiting nowThis study tests a stem cell transplant that removes certain immune cells (alpha/beta T cells and CD19+ B cells) and adds a drug called zoledronic acid. The goal is to help the donor cells attack the tumor without causing severe side effects. It is for children and young adults a…
Matched conditions: RHABDOID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 17, 2026 00:31 UTC
-
New hope for kids with relapsed wilms tumor: drug trial opens
Disease control Recruiting nowThis study tests a drug called selinexor in children and young adults whose Wilms tumor or other solid tumors have come back or not responded to treatment. The goal is to see if the drug can shrink or control the tumors. About 45 participants will receive the drug, and doctors wi…
Matched conditions: RHABDOID TUMOR
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New hope for kids with rare tumor: experimental drug enters phase 2 trial
Disease control Recruiting nowThis study tests a drug called ONO-4538 in 23 people aged 1 year or older with a rare cancer called rhabdoid tumor that has come back or spread and cannot be removed by surgery. The goal is to see if the drug can shrink tumors and help people live longer. Participants must have a…
Matched conditions: RHABDOID TUMOR
Phase: PHASE2 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC